Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Lymphoma, Large B-Cell, Diffuse 2Rhabdoid Tumor 1Recurrence 1Pinealoma 1Neuroectodermal Tumors, Primitive 1Neoplasms, Germ Cell and Embryonal 1Neoplasms 1Nasopharyngeal Carcinoma 1Medulloblastoma 1Glioma 1Ependymoma 1Diffuse Intrinsic Pontine Glioma 1Choroid Plexus Carcinoma 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

X-Rays 7Phantoms, Imaging 7Magnetic Resonance Spectroscopy 7Specimen Handling 6Nuclear Medicine Department, Hospital 5Biopsy 4tazemetostat 3Cyclophosphamide 3ulixertinib 2tipifarnib 2selpercatinib 2palbociclib 2larotrectinib 2ivosidenib 2erdafitinib 2ensartinib 2Vincristine 2Topotecan 2Methotrexate 2LY3023414 2Etoposide 2Cisplatin 2Carboplatin 2talazoparib 1selinexor 1pembrolizumab 1olaparib 1irinotecan sucrosofate 1fludarabine phosphate 1fludarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rhabdoid Tumor × Automobiles × 90 days × Clear all
NCT04185038 2026-04-13

Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors

Seattle Children's Hospital

Phase 1 Recruiting
90 enrolled
CNS

Choroid Plexus Carcinoma, Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Ependymoma, Glioma, Medulloblastoma, Neoplasms, Germ Cell and Embryonal, Pinealoma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡